Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Not applicable

Core Strength Training, Anthropometry, and Postural Control in Youth Optimist Sailors

NCT07802782 · tracked via the Priya Life Science Italy tracker
Phase
Not applicable
Started
2026-09
Last updated
2026-09-03

Condition(s) studied

Postural ControlAthletic PerformancePhysical FitnessCore Stability

Investigational drug(s) / intervention(s)

Core Strength Training (CST)Technical Sailing Training (TST)

Core Strength Training (CST): 12-week periodized, circuit-based core training (3 sessions/week, 8 stations, 3 sets, \~30 min/session) progressing from foundational bodyweight stability to dynamic overload and surface instability.

Technical Sailing Training (TST): Standardized open-water technical sailing training (3-4 hours/session, 3 sessions/week) focusing on hiking postures, boat-handling drills, tactical training, and balance optimization.

Study summary

Optimist dinghy sailing is a highly demanding youth watersport characterized by prolonged, high-intensity isometric hiking postures and rapid dynamic weight shifts required to preserve boat trim, balance, and sail power output. The core (lumbar-pelvic-hip complex) functions as the central dynamic link in transferring kinetic forces between the lower limbs and trunk during continuous open-water maneuvers. This study is designed as a 12-week randomized controlled interventional trial to evaluate the effects of a periodized, circuit-based Core Strength Training (CST) program integrated into routine Technical Sailing Training (TST) compared to TST alone. Primary endpoints evaluate adaptations in the anthropometric profile (skinfold thickness, circumferences, muscle mass percentage) and postural control parameters (Center of Pressure displacement and sway velocity measured via computerized force platform posturography) in competitive youth Optimist sailors.

Eligibility

Sex
ALL
Min age
8 Years
Max age
15 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Active competitive youth Optimist class dinghy sailors aged between 8 and 15 years. * Minimum of 2 consecutive years of continuous competitive sailing experience registered with a recognized national sailing federation or licensed sailing club. * Regular participation in a minimum of 3 technical sailing sessions per week. * Valid sports medical clearance certificate authorizing participation in competitive athletic training. * Signed written informed consent provided by parent(s) or legal guardian(s), accompanied by written informed assent from the participant. Exclusion Criteria: * Acute or chronic musculoskeletal injuries affecting the spine, abdominal wall, lower limbs, or upper extremities within the preceding 6 months. * Concurrent participation in structured external core or strength training programs outside the trial protocol during the preceding 3 months. * Neurological, vestibular, or uncorrected visual impairments affecting balance, posturography, or postural control. * Training adherence rate below 85% of total prescribed sessions over the 12-week interventional period.

Primary outcome measure(s)

  • Static Postural Control: Center of Pressure (CoP) Total Path Length Measured via Computerized Force Platform — Baseline (Week 0) and Post-Intervention (Week 12)
    Total length of the Center of Pressure (CoP) path (expressed in millimeters) recorded during static standing posturography testing under open-eyes and closed-eyes conditions.
  • Static Postural Control: Center of Pressure (CoP) Mean Velocity Measured via Computerized Force Platform — Baseline (Week 0) and Post-Intervention (Week 12)
    Mean velocity of Center of Pressure (CoP) displacement (expressed in millimeters per second) recorded during static standing posturography under open-eyes and closed-eyes conditions.
  • Static Postural Control: Center of Pressure (CoP) 95% Confidence Ellipse Area Measured via Computerized Force Platform — Baseline (Week 0) and Post-Intervention (Week 12)
    Surface area of the 95% confidence ellipse of CoP sway (expressed in square millimeters) recorded during static standing posturography.
  • Dynamic Postural Control: Center of Pressure (CoP) Sway Velocity Measured via Computerized Force Platform — Baseline (Week 0) and Post-Intervention (Week 12)
    Center of Pressure (CoP) mean sway velocity (expressed in millimeters per second) measured during dynamic unstable platform oscillations and unipedal stance.
  • Skinfold Thickness Sum Measured via Skinfold Caliper — Baseline (Week 0) and Post-Intervention (Week 12)
    Sum of skinfold thickness measurements (expressed in millimeters) taken at four sites: triceps, subscapular, suprailiac, and abdominal.
  • Muscle Mass Percentage Measured via Anthropometric Assessment — Baseline (Week 0) and Post-Intervention (Week 12)
    Percentage of total body muscle mass (expressed as % of total body mass) calculated from anthropometric equations.
  • Body Fat Mass Percentage Measured via Anthropometric Assessment — Baseline (Week 0) and Post-Intervention (Week 12)
    Percentage of total body fat mass (expressed as % of total body mass) calculated from skinfold thickness measurements.
  • Waist Circumference Measured via Anthropometric Tape — Baseline (Week 0) and Post-Intervention (Week 12)
    Trunk abdominal waist circumference (expressed in centimeters) measured with a flexible metric tape.

Trial sites (1)

FacilityCityRegionStatus
Outdoor Open-Water Sailing Facility & High-Performance Athletic Training Center Foggia FG
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07802782 on ClinicalTrials.gov ↗ ← All trials in Italy